FibroBiologics Gains Australian Patent for Disc Therapy
Houston, Texas, August 20, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing regenerative therapies based on fibroblast cells and...
Orthopedics
Advertisement
FibroBiologics Advances Cartilage Repair With Cell Therapy
HOUSTON, August 18, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing therapies based on fibroblast cells and fibroblast-derived materials,...
Smith+Nephew Sets New Standard in Sports Medicine AI
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
Advita Ortho Reports First Clinical Use of Activit-E® Humeral Liners
Plantation, Florida, USA — July 24, 2026 Advita Ortho has announced the first clinical use of Equinoxe® Reverse Shoulder...
Regentis Wins European Approval for New GelrinC Process
HERZLIYA, Israel, July 15, 2026 Regentis Biomaterials announced that it has received approval from the European Notified Body for...
Advertisements
Keenova Reports Positive Phase 3 Results for XIAFLEX
DUBLIN, Ireland, July 8, 2026 Keenova Therapeutics plc has announced positive Phase 3 clinical trial results for XIAFLEX® (collagenase...
Advita Ortho Launches Next-Generation Knee Platform in Japan
TOKOROZAWA, Japan, June 30, 2026 Advita Ortho announced the first clinical use of its next-generation knee replacement platform in...
SurGenTec Gains FDA Clearance for ION-L Spine System
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
HERVolution Advances Immune Therapy for Metabolic Disease
COPENHAGEN, Denmark and NEW YORK, June 10, 2026 HERVolution Therapeutics has announced compelling preclinical proof-of-concept data demonstrating the potential...
Smith+Nephew Launches Next-Generation CORI XT Robotics
LONDON, United Kingdom, June 8, 2026 Smith+Nephew has announced the successful completion of the first clinical procedures using its...
Advertisement
